TR200201081A3 - Zayiflatilmis rekombinant kuduz virüs mutantlari ve bu mutantlarin canli asilari - Google Patents

Zayiflatilmis rekombinant kuduz virüs mutantlari ve bu mutantlarin canli asilari

Info

Publication number
TR200201081A3
TR200201081A3 TR2002/01081A TR200201081A TR200201081A3 TR 200201081 A3 TR200201081 A3 TR 200201081A3 TR 2002/01081 A TR2002/01081 A TR 2002/01081A TR 200201081 A TR200201081 A TR 200201081A TR 200201081 A3 TR200201081 A3 TR 200201081A3
Authority
TR
Turkey
Prior art keywords
mutants
weakened
rabies virus
live vaccines
recombinant rabies
Prior art date
Application number
TR2002/01081A
Other languages
English (en)
Other versions
TR200201081A2 (tr
Inventor
Mebatsion Teshome
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR200201081A3 publication Critical patent/TR200201081A3/tr
Publication of TR200201081A2 publication Critical patent/TR200201081A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TR2002/01081A 2001-04-23 2002-04-19 Zayıflatılmış rekombinant kuduz virüs mutantları ve bu mutantların canlı aşıları TR200201081A2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201464 2001-04-23
EP01203773 2001-10-05

Publications (2)

Publication Number Publication Date
TR200201081A3 true TR200201081A3 (tr) 2002-11-21
TR200201081A2 TR200201081A2 (tr) 2002-11-21

Family

ID=26076884

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01081A TR200201081A2 (tr) 2001-04-23 2002-04-19 Zayıflatılmış rekombinant kuduz virüs mutantları ve bu mutantların canlı aşıları

Country Status (10)

Country Link
US (1) US6887479B2 (tr)
EP (1) EP1253197B1 (tr)
AR (1) AR033873A1 (tr)
AT (1) ATE316572T1 (tr)
BR (1) BR0201366A (tr)
CA (1) CA2382993A1 (tr)
DE (1) DE60208854T2 (tr)
ES (1) ES2257505T3 (tr)
PT (1) PT1253197E (tr)
TR (1) TR200201081A2 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007000445A (es) * 2004-07-12 2007-04-16 Univ Jefferson Composiciones de virus de rabia recombinantes-.
AU2006304268B2 (en) 2005-10-14 2011-09-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rabies virus vector systems and compositions and methods thereof
US20100278864A1 (en) * 2005-12-14 2010-11-04 University Of Georgia Research Foundation, Inc. Rabies Vaccine
FR2944292B1 (fr) 2009-04-08 2013-08-23 Sanofi Pasteur Procede de purification du virus rabique
CN103068985A (zh) * 2010-06-24 2013-04-24 美国政府(由卫生和人类服务部、疾病控制和预防中心的部长所代表) 抗狂犬病的广谱狂犬病病毒属病毒疫苗
ES2528472T3 (es) 2011-02-03 2015-02-10 The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services Vacunas multivalentes para el virus de la rabia y filovirus
EP4104854A3 (en) 2016-04-04 2023-03-08 The United States of America as represented by the Secretary of the Department of Health and Human Services Multivalent vaccines for rabies virus and coronaviruses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6719981B1 (en) * 1998-11-27 2004-04-13 Akzo Nobel N.V. Stable, attenuated rabies virus mutants and live vaccines thereof

Also Published As

Publication number Publication date
DE60208854D1 (de) 2006-04-13
AR033873A1 (es) 2004-01-07
EP1253197B1 (en) 2006-01-25
EP1253197A1 (en) 2002-10-30
TR200201081A2 (tr) 2002-11-21
ES2257505T3 (es) 2006-08-01
US20020164356A1 (en) 2002-11-07
ATE316572T1 (de) 2006-02-15
DE60208854T2 (de) 2006-08-17
PT1253197E (pt) 2006-06-30
US6887479B2 (en) 2005-05-03
BR0201366A (pt) 2003-06-10
CA2382993A1 (en) 2002-10-23

Similar Documents

Publication Publication Date Title
CY2016018I2 (el) Εμβολιο κατα του ιου του δυτικου νειλου
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
AU2003235707A8 (en) Immunogenic preparations and vaccines on the basis of mrna
NO20020400D0 (no) Sekvenser og fremgangsmåter for påvisning av hepatitt C-virus
CY2014010I1 (el) Εμβολιο δυτικου νειλου
DE60124863D1 (de) Gegen menschliche interleukin-1-beta gerichtete rekombinante antikörper
NO20021431D0 (no) Intranasal influensavirusvaksine
AU4932601A (en) Recombinant parainfluenza virus expression systems and vaccines
IL147969A0 (en) Peptides that block viral infectivity and methods of use thereof
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
EP1497654A4 (en) IMMUNOGLOBULIN E VACCINES AND METHODS OF USE
NO20030239L (no) Modifisert virus
TR200201081A3 (tr) Zayiflatilmis rekombinant kuduz virüs mutantlari ve bu mutantlarin canli asilari
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
EP1651258A4 (en) HEPATITIS VIRUS CORE PROTEINS AS VACCINE PLATFORMS AND USE THEREOF
IL131212A0 (en) Recombinant virus and live-virus vaccines
NO20033829L (no) Virusdrepende preparater
ATE392903T1 (de) Impfstoff gegen pferdeherpesvirus
DK1248650T3 (da) Forbedrede DNA-vacciner til bovint herpesvirus 1
ATE356202T1 (de) Attenuierte stabile tollwutvirusmutante und lebende impfstoffe
AU2002318104A1 (en) Microparticles and methods for delivery of recombinant viral vaccines
NO20020399D0 (no) Sekvenser og fremgangsmåter for påvisning av hepatitt B-virus
AU2003287216A8 (en) Gb virus c and methods of treating viral infections
IS2797B (is) Bóluefni gegn ISA-veiru
IL149173A0 (en) Attenuated recombinant rabies virus mutants and live vaccines thereof